DANIEL MARINELLI: Open Payments
NPI 1841813300 · INVERNESS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$604 in 27 payments from 11 companies in 2025. Trend: 2023 $448 · 2024 $659 · 2025 $604
Food & beverage: $604
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 6 | $133 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $109 |
| AstraZeneca Pharmaceuticals LP | 5 | $88 |
| Amgen Inc. | 4 | $61 |
| Boston Scientific Corporation | 1 | $50 |
| Merck Sharp & Dohme LLC | 2 | $50 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| SCPHARMACEUTICALS INC. | 1 | $26 |
| Novo Nordisk Inc | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: VYNDAQEL, LifeVest, REPATHA, FARXIGA, WATCHMAN FLX, LEQVIO, VERQUVO, FUROSCIX.
Industry payments across FL — which companies pay providers there.
